DocWire News Editors

DocwireNews

Edward Faught, MD, professor of neurology, Emory University School of Medicine, and director, Emory Epilepsy Program, gave a presentation titled Epilepsy: Diagnosis, Treatment, and Levels of Care in a session in the Health Management II track. The presentation provided basic facts about epilepsy, information on drugs used in treatment of patients with epilepsy, levels of care, new technologies for diagnosis and surgery, and the future of epilepsy care.Epilepsy is defined as &ge;2 unprovoked seizures or one unprovoked seizure with at least a 70% chance of recurrence. There are approximately 50 patients per 100,000 individuals diagnosed with epilepsy each year (43 in developed countries; 80+ in developing countries). There are two categories of seizures: (1)&nbsp;focal; seizures that start in one part of the brain, from a focal lesion; most common in adults; (2)&nbsp;generalized; seizures that start bilaterally in the brain; most common in children; usually genetic.The costs of care, both direct and indirect, are high. Patients often experience comorbidities; seizures may result in injury or death (SUDEP&mdash;sudden death in epilepsy). Epilepsy often leads to psychosocial problems and &ldquo;even an occasional seizure can be devastating socially and psychologically,&rdquo; Dr. Faught said.Current treatment recommendations call for medications (100% of patients), surgery (10% of patients, one in three can stop medications); electrical neuromodulation, either extracranial (vagal nerve stimulator) or intracranial (responsive neurostimulator); and ketogenic diets (1% of patients, mostly children).Dr. Faught described the four levels of epilepsy care:<ul>
<li>Initial diagnosis and treatment, including decisions regarding choice of medication. Popular medications for first-line therapy include levetiracetam, carbamazepine, lamotrigine, or topiramate.</li>
<li>Neurologist care, should be involved within 3 months of seizure onset. The neurologist will order an epilepsy-specific MRI and an EEG, and adjust medication based on serum levels. Consideration regarding addition of a second drug will also be made.</li>
<li>Epileptologist care&nbsp;provides an additional level of experience in epilepsy or clinical neurophysiology and enhanced knowledge of second-level drugs.</li>
<li>Comprehensive epilepsy center care&nbsp;is commonly available at academic medical centers and provides patient access to neuropsychology, rehabilitation, and social services, as well as management of unusual drugs and clinical trials of experimental drugs.</li>
</ul>Addressing the question of which antiepileptic drugs should be on the formulary, Dr. Fraught noted that step therapy does not work due to variation and unpredictability of individual response. &ldquo;Formularies should contain commonly used drugs and probably at least one drug from each category of mechanism of action. Drugs with the same mechanism of action are not necessarily redundant because nearly all antiepileptic drugs have more than one mechanism of action, often unknown,&rdquo; he said.Dr. Fraught continued with a discussion on surgical therapy for epilepsy. Surgical therapy should be considered when &ge;2 appropriate antiepileptic drugs have failed and is highly effective for selected patients with focal seizures. Sixty percent to 80% of patients are seizure-free following surgery for temporal lobe foci; 40% to 60% have positive results after surgery for other brain locations.The session concluded with a brief overview of future directions for epilepsy care, including more minimally invasive surgery (laser, radiofrequency), gene therapy, personalized medicine, and medication to prevent epilepsy.<ol start="2017">
<li>Edward Faught, MD. Clinical Insights into the Diagnosis and Treatment of Epilepsy. 2017 Fall Managed Care Forum. October 27, 2017.</li>
</ol>

MarkAlain Déry, DO

The Significant Danger Measles Pose for Unvaccinated Children

Infectious Disease

Andrew Moreno

Antithrombotic Care in Hemophilia: A Summary of Multi-Organizational Clinical Practice Guidance

Hemophilia

James Tumlin, MD

Joel M. Topf, MD, FACP

Proteinuria Remission With Sparsentan in FSGS

NKF Spring Clinical Meetings 2025

Latest News

Care Management for Patients with Epilepsy

NAMCP 2017

Edward Faught, MD, professor of neurology, Emory University School of Medicine, and director, Emory Epilepsy Program, gave a presentation titled Epilepsy: Diagnosis, ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe